Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_assertion type Assertion NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_head.
- NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_assertion wasGeneratedBy ECO_0000203 NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_provenance.
- NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_assertion wasDerivedFrom befree-20140225 NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_provenance.
- NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_assertion SIO_000772 12376482 NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_provenance.
- NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_assertion evidence source_evidence_literature NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_provenance.
- NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_assertion description "[We found that, unlike benzo[a]pyrene trans-7,8-dihydrodiol-9,10-epoxide-DNA adduction, which preferentially occurs at CpG sites, 4-ABP-DNA adduction is not biased for CpG sites, and the adducts are more evenly distributed along the p53 gene; nonetheless, the p53 mutational hotspots in bladder cancer at codons 175, 248, 280 and 285 are also the preferential sites for 4-ABP adduct formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262367.RAlQxoSCv2e2yHofcmxka8z9wVyyEIDz6EdCjZ_XUJDZ0130_provenance.